Pseudo-pseudo Meigs Syndrome as the first clinical manifestation of systemic lupus erythematosus after controlled ovarian stimulation for ICSI: a case report
4 affiliations
- 1Department of Emergency, West China Second University Hospital, Sichuan University
- 2Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education
- 3Department of Physiology, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University
- 4Department of Cancer Center, West China Second University Hospital, Sichuan University
Abstract
Background: Pseudo-pseudo Meigs syndrome (PPMS), or Tjalma syndrome, is a rare systemic lupus erythematosus (SLE)-associated phenotype characterized by ascites, pleural effusion, and elevated CA125 without an ovarian neoplasm. After assisted reproductive technology (ART), it may overlap with ovarian hyperstimulation syndrome (OHSS) or mimic gynecologic malignancy.
Case presentation: A 25-year-old woman underwent two controlled ovarian stimulation (COS) cycles for intracytoplasmic sperm injection (ICSI) because of severe male-factor infertility. Before ART, she had autoimmune thyroid disease and transient urinary abnormalities, but no known SLE. During the second COS cycle, hypertension and albuminuria emerged. Following oocyte retrieval, she developed massive ascites, bilateral pleural effusions, adnexal abnormalities, and marked CA125 elevation, initially raising suspicion of OHSS and ovarian malignancy. Subsequent nephrotic-range proteinuria, profound hypoalbuminemia, hypocomplementemia, and SLE-associated autoantibodies supported active SLE with substantial renal involvement. Cytologic and microbiologic investigations provided no evidence of malignancy or infection. Following SLE-directed treatment, renal abnormalities and serosal effusions improved. At eight months, the adnexal abnormalities had completely resolved and CA125 had normalized, supporting a PPMS phenotype.
Conclusion: Atypical or persistent post-ART effusions, particularly when accompanied by evolving renal or immunologic abnormalities, should prompt consideration of SLE-associated PPMS as an important differential diagnosis beyond OHSS and gynecologic malignancy. Longitudinal evaluation and multidisciplinary assessment may facilitate timely recognition of this rare phenotype and guide appropriate clinical management.
Related
- Third lumbar transverse process syndrome with acute abdominal pain as the main clinical manifestation: A case report.
- Efficacy of diadynamic currents versus transcutaneous electrical nerve stimulation for transcutaneous tibial nerve stimulation in subjects with overactive bladder syndrome: A double-blind randomized controlled trial
- Case Report: mNGS-negative Strongyloides hyperinfection syndrome with small bowel obstruction as the initial manifestation in a glucocorticoid-exposed COPD patient: a fatal case
- Thrombotic microangiopathy in a patient with systemic lupus erythematosus and systemic sclerosis overlap syndrome: a case report and review of the literature
- Cutaneous efficacy and glucocorticoid-sparing effects of anifrolumab in systemic lupus erythematosus: a systematic review and meta-analysis of randomized controlled trials
BibTeX
@article{li2026pseudopseudo,
title = {{Pseudo-pseudo Meigs Syndrome as the first clinical manifestation of systemic lupus erythematosus after controlled ovarian stimulation for ICSI: a case report}},
author = {Sicong Li and Dan Zhao and Mengpei Zhang},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1936700},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1936700/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Pseudo-pseudo Meigs Syndrome as the first clinical manifestation of systemic lupus erythematosus after controlled ovarian stimulation for ICSI: a case report
AU - Sicong Li
AU - Dan Zhao
AU - Mengpei Zhang
PY - 2026
DA - 2026/10/22
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1936700
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1936700/full
AB - Background: Pseudo-pseudo Meigs syndrome (PPMS), or Tjalma syndrome, is a rare systemic lupus erythematosus (SLE)-associated phenotype characterized by ascites, pleural effusion, and elevated CA125 without an ovarian neoplasm. After assisted reproductive technology (ART), it may overlap with ovarian hyperstimulation syndrome (OHSS) or mimic gynecologic malignancy. Case presentation: A 25-year-old woman underwent two controlled ovarian stimulation (COS) cycles for intracytoplasmic sperm injection (ICSI) because of severe male-factor infertility. Before ART, she had autoimmune thyroid disease and transient urinary abnormalities, but no known SLE. During the second COS cycle, hypertension and albuminuria emerged. Following oocyte retrieval, she developed massive ascites, bilateral pleural effusions, adnexal abnormalities, and marked CA125 elevation, initially raising suspicion of OHSS and ovarian malignancy. Subsequent nephrotic-range proteinuria, profound hypoalbuminemia, hypocomplementemia, and SLE-associated autoantibodies supported active SLE with substantial renal involvement. Cytologic and microbiologic investigations provided no evidence of malignancy or infection. Following SLE-directed treatment, renal abnormalities and serosal effusions improved. At eight months, the adnexal abnormalities had completely resolved and CA125 had normalized, supporting a PPMS phenotype. Conclusion: Atypical or persistent post-ART effusions, particularly when accompanied by evolving renal or immunologic abnormalities, should prompt consideration of SLE-associated PPMS as an important differential diagnosis beyond OHSS and gynecologic malignancy. Longitudinal evaluation and multidisciplinary assessment may facilitate timely recognition of this rare phenotype and guide appropriate clinical management.
SN - 1664-3224
ER -